Pharmacotherapy of recurrent respiratory papillomatosis

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 8, 2002, Pages 1091-1099

  Kimberlin, David W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cidofovir; Human papillomavirus; Indole 3 carbinol; Interferon; Laryngeal papillomatosis; Papillomatosis; Respiratory papillomatosis

Indexed keywords

3 INDOLEMETHANOL; ALPHA2A INTERFERON; CIDOFOVIR; METHOTREXATE; RETINOIC ACID DERIVATIVE; RIBAVIRIN; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTHRALGIA; BONE MARROW TOXICITY; CAUTERIZATION; CHILD; CHILL; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; KIDNEY DISEASE; LARYNX SURGERY; MYALGIA; NEPHROTOXICITY; NEUTROPENIA; PAPILLOMATOSIS; PERSISTENT VIRUS INFECTION; PHOTODYNAMIC THERAPY; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; VIRUS GENOME; WART VIRUS; CLASSIFICATION; CLINICAL TRIAL; EXPERT WITNESS; LARYNX TUMOR; NEWBORN; PAPILLOMA;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CLINICAL TRIALS; EXPERT TESTIMONY; HUMAN; INFANT, NEWBORN; LARYNGEAL NEOPLASMS; PAPILLOMA; RECURRENCE; HUMANS;

EID: 0035989229     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.8.1091     Document Type: Review

References (108)

1. Innesto positivo con filtrato di verruca vulgare
2. Infectious papillomatosis of rabbits
3. Animal papillomaviruses
4. Heterogeneity of the human papillomavirus group
5. Demonstration of human papillomavirus types 6 and 11 in juvenile laryngeal papillomatosis by in-situ DNA hybridization
6. Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis
7. Laryngeal papillomavirus infection during clinical remission
8. Latent papillomavirus and recurring genital warts
9. Papillomaviruses
10. Persistence and expression of human papillomavirus during interferon therapy
11. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population
12. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears
13. Papillomavirus
14. Cancer mortality among nuns: Role of marital status in etiology of neoplastic disease in women
15. Genital cancer in wives of penile cancer patients
16. Epidemiology of cervical cancer - Overview
17. Papillomaviruses
18. Genital papillomavirus infections
19. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma
20. Current views on cervical intraepithelial neoplasia
21. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
22. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus Type 16 DNA
23. Comparison of the in vitro transforming activities of human papillomavirus types
24. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma
25. Premalignant lesions and cancers of the skin in the general population: Evaluation of the role of human papillomaviruses
26. Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients
27. Integration and transcription of human papillomavirus Type 16 and 18 sequences in cell lines derived from cervical carcinomas
28. Human papillomavirus Type 16 and 18 gene expression in cervical neoplasias
29. Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites
30. Human papillomavirus Type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization
31. Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study
32. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
33. Relationship between human papillomavirus infection and tumors of anogenital sites other than the cervix
34. Association of human papillomaviruses (HPV) with other female genital tract tumors
35. Human papillomavirus infections in the respiratory tract
36. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck
37. Contribution to the etiology of laryngeal papilloma in children
38. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis
39. Task force on recurrent respiratory papillomas. A preliminary report
40. The cost of juvenile-onset recurrent respiratory papillomatosis
41. Recurrent respiratory papillomatosis
42. Benign neoplasms of the larynx
43. Recurrent respiratory papillomatosis in children: A retrospective study of management and complications
44. Pulmonary manifestations of juvenile laryngotracheal papillomatosis
45. Tracheotomy in children with recurrent respiratory papillomatosis
46. Laryngeal papilloma: Etiologic and therapeutic considerations
47. Relationship between condylomata and laryngeal papillomata. Clinical and molecular virological evidence
48. Laryngeal papillomatosis: Clinical, histopathologic and molecular studies
49. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis
50. Transmission of human papillomaviruses from mother to child
51. Risk factors for juvenile onset recurrent respiratory papillomatosis
52. Oral and laryngeal papilloma: A pediatric manifestation of sexually transmitted disease?
53. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis
54. Recurrent respiratory papillomatosis - The Manchester experience, 1974-1992
55. Pediatric respiratory papillomatosis: Prognostic role of viral typing and cofactors
56. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease
57. Benign and malignant papilloma of the larynx in adults
58. Laryngeal papilloma: Review of etiology and therapy
59. Malignant transformation in non-irradiated recurrent respiratory papillomatosis
60. Carcinoma ex-papilloma: Histologic and virologic studies in whole-organ sections of the larynx
61. Propagation of human papillomavirus Type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model
62. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata
63. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation
64. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures
65. In vitro experimental systems for HPV: Epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences
66. Recurrent respiratory papillomatosis
67. Use of a laryngeal microresector system
68. A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: Preliminary report
69. A new laser treatment for vocal cord papilloma-585-nm pulsed dye
70. Treatment of recurrent respiratory papillomatosis with argon plasma coagulation
71. Interferons: Bichemical, cell growth, inhibitory, and immunological effects
72. Antiviral agents and interferons
73. Interferon alpha in malignant and viral diseases: A review
74. Interferon induced antiviral actions and their regulation
75. Side effects of alpha interferon
76. Interferons as mediators of psychiatric morbidity
77. Treatment of chronic viral hepatitis with alpha interferon: A consensus conference report
78. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial
79. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1
80. Interferon therapy in juvenile laryngeal papillomatosis
81. Results of treatment with alpha-interferon in adult-onset laryngeal papillomatosis
82. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis
83. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy
84. Isotretinoin therapy for recurrent respiratory papillomatosis
85. The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: A randomized pilot study
86. Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study
87. Acyclovir in the treatment of recurrent respiratory papillomatosis: A preliminary report
88. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas
89. Variable light-dose effect on photodynamic therapy for laryngeal papillomas
90. Recurrent respiratory papillomatosis associated with gastroesophageal reflux disease in children
91. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: Immediate and long-term results
92. Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus
93. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis
94. Cimetidine treatment for recurrent respiratory papillomatosis
95. Treatment of recurrent respiratory papillomatosis with indole-3-carbinol
96. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis
97. Recurrent respiratory papillomatosis
98. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl) cytosine]
99. Intralesional cidofovir for recurrent respiratory papillomatosis in children
100. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis
101. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort
102. Antiviral agent cidofivir restores p53 function and enhances the radiosensitivity in HPV-associated cancers
103. Systemic cidofovir in papillomatosis
104. Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b
105. Prognostic value of clinical findings in histologically verified adult-onset laryngeal papillomas
106. Juvenile onset recurrent respiratory papillomatosis: Possibilities for successful antiviral therapy